One-week triple therapy with esomeprazole, clarithromycin and metronidazole provides effective eradication of Helicobacter pylori infection

Alimentary Pharmacology and Therapeutics

Volumn 17, Issue 11, 2003, Pages 1381-1387

  Veldhuyzen Van Zanten, S ^a   Machado, S ^b   Lee, J ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; ESOMEPRAZOLE; METRONIDAZOLE; OMEPRAZOLE;

ADULT; AGED; ALLERGIC REACTION; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; DYSPEPSIA; DYSPNEA; EPIGASTRIC PAIN; ERADICATION THERAPY; FEMALE; FLATULENCE; HEADACHE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTERMETHOD COMPARISON; LARYNGITIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOSIS; NAUSEA; PEPTIC ULCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; TASTE DISORDER; THORAX PAIN; TREATMENT OUTCOME; UREA BREATH TEST; VAGINITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; PATIENT COMPLIANCE; TREATMENT OUTCOME;

EID: 0038772377     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01554.x     Document Type: Article

References (22)

1. Malfertheiner P, Megraud R, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection - The Maastricht 2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167-80.
2. Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus Conference on the Management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998; 13: 1-12.
3. Hunt RH, Eallone C, Veldhuyzen van Zanten SJO, et al. Risks and benefits of Helicobacter pylori eradication: current status. Can J Gastroenterol 2002; 16: 57-62.
4. Gisbert JP, Gonzalez L, Calvet X, et al. Proton pump inhibitor, clarithromycin and either amoxicillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther 2000; 14: 1319-28.
5. Calvet X, Garcia N, Lopez T, Gisbert JP, Gene E, Roque M. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxicillin for treating Helicobacter pylori infection. Aliment Pharmacol Ther 2000; 14: 603-9.
6. Fischbach LA, Goodman KJ, Feldman M, Aragaki C. Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis. Int J Epidemiol 2002; 31: 128-39.
7. Laheij RJF, Van Rossum LGM, Jansen JBMJ, Straatman H, Verbeek ALM. Evaluation of treatment regimens to cure Helicobacter pylori infection - a meta-analysis. Aliment Pharmacol Ther 1999; 13: 857-64.
8. Lind T, Rydberg L, Kylebäck A, et al. Esomeprazole provides improved acid control versus omeprazole in patients with symptoms of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2000; 14: 86-7.
9. Kahrilas PJ, Falk GW, Johnson DA, et al. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. Aliment Pharmacol Ther 2000; 14: 1249-58.
10. Rohss K, Hasselgren G, Hedenstrom H. Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease. Dig Dis Sci 2002; 47: 954-8.
11. Veldhuyzen van Zanten SJO, Lauritsen K, Delchier JC, et al. One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease. Aliment Pharmacol Ther 2000; 14: 1605-11.
12. Laine L, Fennerty MB, Osato M, et al. Esomeprazole-based Helicobacter pylori eradication therapy and the effect of anti-biotic resistance: results of three US multicentre double-blind trials. Am J Gastroenterol 2000; 95: 3393-8.
13. Tulassay Z, Kryszewski A, Dite P, et al. One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease. Eur J Gastroenterol Hepatol 2001; 13: 1457-65.
14. Veldhuyzen van Zanten SJO, Flook N, Chiba N, et al. An evidence-based approach to the management of patients with dyspepsia in the era of Helicobacter pylori. Can Med Assoc 2000; 162(Suppl. 12): S3-23.
15. 13C urea breath test used for the diagnosis of Helicobacter pylori infection. Clin Biochem 1999; 32: 59-63.
16. Chiba N, Veldhuyzen van Zanten SJO, Sinclair P, Ferguson RA, Escobedo S, Grace E. Treatment of H. pylori infection in primary care patients with uninvestigated dyspepsia improves symptoms: The CADET-Hp (Canadian Adult Dyspepsia Empiric Treatment - Helicobacter pylori Positive) randomised controlled trial. Br Med J 2002; 324: 1012-6.
17. Fallone CA. Epidemiology of the antibiotic resistance of Helicobacter pylori in Canada. Can J Gastroenterol 2000; 14: 879-82.
18. Best LM, Haldane DJM, Veldhuyzen van Zanten SJO. Susceptibility of Canadian strains of Helicobacter pylori to metronidazole and clarithromycin using four assay methods. Can J Gastroenterol 1998; 12 (Suppl A); 106A(S92).
19. Best LM, Haldane DJM, Bezanson GS, Velhuyzen van Zanten SJO. Helicobacter pylori: primary susceptibility to clarithromycin in vitro in Nova Scotia. Can J Gastroenterol 1997; 11(4): 298-300.
20. Meyers JM, Silliman NP, Wang W, et al. Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999. Ann Intern Med 2002; 136: S-67.
21. Lind T, Megraud F, Unge P, et al. The MACH 2 study: role of omeprazole in eradication of Helicobacter pylori with one-week triple therapies. Gastroenterology 1999; 116: 248-53.
22. Veldhuyzen van Zanten SJO, Bradette M, Farley A, et al. The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther 1999; 13: 289-95.